Changes in Thyroid Stimulating Hormone Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves’ Disease-Reference-Cited by-同舟云学术

Changes in Thyroid Stimulating Hormone Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves’ Disease

Published:2021-05-05 Issue: Volume: Page:
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Kim Jinyoung¹,Choi Min Sun¹,Park Jun¹,Park Hyunju¹,Jang Hye Won²,Choe Jun-Ho³,Kim Jung Han³,Kim Jee Soo³,Cho Young Seok⁴,Choi Joon Young⁴,Kim Tae Hyuk¹,Chung Jae Hoon¹,Kim Sun Wook⁵⁶

Affiliation:

1. Samsung Medical Center, 36626, Division of Endocrinology and Metabolism, Department of Medicine, Gangnam-gu, Seoul, Korea (the Republic of), ;

2. Sungkyunkwan University School of Medicine, 35019, Department of Medical Education, Suwon, Korea (the Republic of), ;

3. Samsung Medical Center, 36626, Division of Endocrine Surgery, Department of Surgery, Gangnam-gu, Seoul, Korea (the Republic of), ;

4. Samsung Medical Center, 36626, Department of Nuclear Medicine, Gangnam-gu, Seoul, Korea (the Republic of), ;

5. Samsung Medical Center, 36626, Division of Endocrinology and Metabolism, Department of Medicine, Gangnam-gu, Seoul, Korea (the Republic of),

6. Sungkyunkwan University School of Medicine at Samsung Medical Center Cancer Center, 371718, Department of Internal Medicine, Gangnam-gu, Seoul, Korea (the Republic of), ;

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2020.0756

Reference31 articles.

1. Clinical Utility of TSH Receptor Antibodies

2. Comparison of Five TSH-Receptor Antibody Assays in Graves’ disease: results from an observational pilot study

3. TSH receptor autoantibody immunoassay in patients with Graves' disease: Improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis

4. Thyroid-Stimulating Antibody is Related to Graves' Ophthalmopathy, But Thyrotropin-Binding Inhibitor Immunoglobulin is Related to Hyperthyroidism in Patients with Graves' Disease

5. Graves' Ophthalmopathy

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced predictive validity of integrative models for refractory hyperthyroidism considering baseline and early therapy characteristics: a prospective cohort study;Journal of Translational Medicine;2024-03-29

2. Die aktualisierte DGN-Handlungsempfehlung zur Radiojodtherapie gutartiger Schilddrüsenerkrankungen: differenzierte Einordnung neuer Aspekte;Nuklearmedizin - NuclearMedicine;2023-10-23

3. DGN-Handlungsempfehlung (S1-Leitlinie): Radiojodtherapie bei benignen Schilddrüsenerkrankungen (Stand 6/2022 – AWMF-Registernummer: 031-003) – Radiojodtherapie bei benignen Schilddrüsenerkrankungen;Nuklearmedizin - NuclearMedicine;2023-10-23

4. Progressive Thymic Hyperplasia With Graves’ Disease: A Case Report;Cureus;2023-08-22

5. The Correlation of Thyroid Hormone Levels and Anti-Thyroidal Drugs on Thyroid Size, Weight, and Ease of Surgical Dissection for Thyroidectomy for Graves’ Disease;The American Surgeon™;2023-07-28